Zandy Forbes is CEO and co-founder of MeiraGTx, a NASDAQ-listed clinical-stage genetic medicine company. She has spoken about her own journey from academia into biotech leadership, and MeiraGTx's approach to developing gene therapies for rare and common diseases.

She holds a double first in Natural Sciences from Cambridge University and a PhD in Molecular Genetics from the University of Oxford.